Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11725007 | Meta tyrosine derivatives as rho-kinase inhibitors | Alessandro Accetta, Fabio Rancati, Christine Edwards, Patrizia Tisselli | 2023-08-15 |
| 11147812 | Tyrosine analogues derivatives as Rho-kinase inhibitors | Alessandro Accetta, Anna Maria Capelli, Fabio Rancati, Arnaud Jean Francois Auguste Cheguillaume, Christine Edwards +1 more | 2021-10-19 |
| 10954236 | Tyrosine amide derivatives as Rho-Kinase inhibitors | Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Patrizia Tisselli +2 more | 2021-03-23 |
| 10584128 | Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors | Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Patrizia Tisselli +1 more | 2020-03-10 |
| 10501461 | Tyrosine amide derivatives as Rho-kinase inhibitors | Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Patrizia Tisselli +2 more | 2019-12-10 |
| 9643983 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Emma Budd, Graham Charles Bloomfield, Stephen Paul Collingwood, Andrew Dunstan, Lee Edwards +6 more | 2017-05-09 |
| 9522149 | Pyrazine derivatives as ENaC blockers | Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith | 2016-12-20 |
| 9139586 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Emma Budd, Graham Charles Bloomfield, Stephen Paul Collingwood, Andrew Dunstan, Lee Edwards +6 more | 2015-09-22 |
| 9050339 | Pyrazine derivatives as ENaC blockers | Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith | 2015-06-09 |
| 8697687 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Emma Budd, Graham Charles Bloomfield, Stephen Paul Collingwood, Andrew Dunstan, Lee Edwards +6 more | 2014-04-15 |
| 8546416 | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | Ameet Vijay Ambarkhane, Martin Beckett, James Dale, Ahmed Hamadi, Alessandro MAZZACANI +2 more | 2013-10-01 |
| 8372845 | Pyrazine derivatives as enac blockers | Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith | 2013-02-12 |
| 8168654 | Quinuclidine derivatives binding to mucarinic M3 receptors | Stephen Paul Collingwood, Brian Cox, Urs Baettig, Nicholas James Devereux | 2012-05-01 |
| 8039472 | Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel | Emma Budd, Graham Charles Bloomfield, Stephen Paul Collingwood, Andrew Dunstan, Lee Edwards +6 more | 2011-10-18 |
| 7754758 | Pyrrolidine derivatives acting as CCR3-receptor antagonists | Andrew Dunstan, Angela Glen, Trevor John Howe, Clive McCarthy | 2010-07-13 |
| 7361661 | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors | Stephen Paul Collingwood, Robin Alec Fairhurst, Sylvie Gomez, Reto Naef, David Andrew Sandham | 2008-04-22 |
| 7259173 | Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions | Clive Victor Walker | 2007-08-21 |
| 7034042 | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33 receptor antagonists | Trevor John Howe, Darren Mark Le Grand | 2006-04-25 |
| 7019136 | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors | Stephen Paul Collingwood, Robin Alec Fairhurst, Sylvie Gomez, Reto Naef, David Andrew Sandham | 2006-03-28 |
| 6919337 | 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors | Stephen Paul Collingwood, Robin Alec Fairhurst, Sylvie Gomez, Ret Naef, David Andrew Sandham | 2005-07-19 |
| 6670379 | Piperidine compounds for use as ccr-3 inhibitors | Trevor John Howe, Darren Mark Le Grand, Thomas Storz | 2003-12-30 |
| 6114468 | Synthetic resins for use in solid phase synthesis | — | 2000-09-05 |